ALLMedicine™ Fibrolamellar Carcinoma Center
Research & Reviews 111 results
https://doi.org/10.1159/000513358
Oncology Gottlieb S, O'Grady C et. al.
Mar 10th, 2021 - There are no standard systemic therapies for the treatment of fibrolamellar carcinoma (FLC), as surgery remains the only definitive option. We share our experiences using systemic "triple therapy" (TT) with 5-fluorouracil, interferon, and nivoluma...
https://doi.org/10.1016/j.ejca.2020.06.035
European Journal of Cancer (Oxford, England : 1990); Lamarca A, Frizziero M et. al.
Aug 9th, 2020 - Fibrolamellar carcinoma (FLC) is a rare and poorly understood malignancy, which seems to be more prevalent in young patients compared with conventional hepatocellular carcinoma (HCC). Performing prospective clinical trials recruiting patients diag...
https://doi.org/10.1002/cncr.32960
Cancer References; El Dika I, Bowman AS et. al.
Jul 14th, 2020 - Fibrolamellar carcinoma (FLC) is a rare primary liver cancer of young adults. A functional chimeric transcript resulting from the in-frame fusion of the DNAJ homolog, subfamily B, member 1 (DNAJB1), and the catalytic subunit of protein kinase A (P...
https://doi.org/10.1177/1066896920933344
International Journal of Surgical Pathology; du Toit M, Aldera AP
Jun 8th, 2020 - Biopsies of liver mass lesions are encountered frequently in general surgical pathology practice. The clinical differential diagnosis is typically hepatocellular carcinoma (HCC) versus metastatic adenocarcinoma. There are a variety of HCC variants...
https://doi.org/10.1016/j.mayocp.2020.04.024
Mayo Clinic Proceedings; Erickson LA
Jun 4th, 2020 - Fibrolamellar Carcinoma.|2020|Erickson LA,|
Clinicaltrials.gov 113 results
https://doi.org/10.1159/000513358
Oncology Gottlieb S, O'Grady C et. al.
Mar 10th, 2021 - There are no standard systemic therapies for the treatment of fibrolamellar carcinoma (FLC), as surgery remains the only definitive option. We share our experiences using systemic "triple therapy" (TT) with 5-fluorouracil, interferon, and nivoluma...
https://doi.org/10.1016/j.ejca.2020.06.035
European Journal of Cancer (Oxford, England : 1990); Lamarca A, Frizziero M et. al.
Aug 9th, 2020 - Fibrolamellar carcinoma (FLC) is a rare and poorly understood malignancy, which seems to be more prevalent in young patients compared with conventional hepatocellular carcinoma (HCC). Performing prospective clinical trials recruiting patients diag...
https://doi.org/10.1002/cncr.32960
Cancer References; El Dika I, Bowman AS et. al.
Jul 14th, 2020 - Fibrolamellar carcinoma (FLC) is a rare primary liver cancer of young adults. A functional chimeric transcript resulting from the in-frame fusion of the DNAJ homolog, subfamily B, member 1 (DNAJB1), and the catalytic subunit of protein kinase A (P...
https://doi.org/10.1177/1066896920933344
International Journal of Surgical Pathology; du Toit M, Aldera AP
Jun 8th, 2020 - Biopsies of liver mass lesions are encountered frequently in general surgical pathology practice. The clinical differential diagnosis is typically hepatocellular carcinoma (HCC) versus metastatic adenocarcinoma. There are a variety of HCC variants...
https://doi.org/10.1016/j.mayocp.2020.04.024
Mayo Clinic Proceedings; Erickson LA
Jun 4th, 2020 - Fibrolamellar Carcinoma.|2020|Erickson LA,|
News 2 results
https://www.mdedge.com/gihepnews/article/198920/liver-disease/microrna-375-may-be-key-fibrolamellar-carcinoma?channel=69
Will Pass, MDedge News
Apr 15th, 2019 - Up-regulation of microRNA-375 may be a future therapeutic strategy for patients with fibrolamellar carcinoma (FLC), according to investigators. Analysis of primary FLC tumors showed that microRNA-375 was the most abnormal microRNA, down-regulated.
https://www.medscape.com/viewarticle/475293
May 17th, 2004 - Summary 38 year old female with worst headache of life. (Enlarge Image) (Enlarge Image) (Enlarge Image) (Enlarge Image) (Enlarge Image) A tumor of the liver associated with prior exposure to Thorotrast: Hemangioma Angiosarcoma FNH Fibrolamellar ca...
